Found: 1
Select item for more details and to access through your institution.
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 521, doi. 10.1634/theoncologist.2018-0290
- By:
- Publication type:
- Article